tirzepatide semaglutide weight loss outperformed weight-loss drug results in real world patients, study shows GLP-1 Medications for Weight Loss:

The percentage of suicide risk observed in our sample of women at 18 months postpartum was 24.4% ( n = 11) and of women without suicide risk was 75.6% ( n = 34)

Before your surgery, your care team will be sure to go over all the details of your procedure, including how long youll be in the operating room, so all your specific questions are answered

In: American Diabetes Associations 83rd Scientific Sessions

GLP-1 receptor agonists (such as exenatide, liraglutide, dulaglutide, and semaglutide) commonly cause nausea, vomiting, and abdominal discomfort, particularly during the initial weeks of treatment

It remains an investigational compound available only through clinical trial participation